Differential methylation of AKT1 in blood was associated with clinical post-traumatic stress disorder in combat veterans114, and in post-mortem brain of schizophrenia patients compared to unaffected controls115, while changes in its expression level in blood were positively correlated with improvement of depression symptoms among bipolar disorder patients treated with lithium116. This evidence concerns the gene AKT1 and depressive symptom measurement.